Kimberly Lapham

3PUBLICATIONS
3CO-AUTHORS
Biomolecular modelling and designMolecular targetsWastewater treatment processes
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Aug 14, 2024
Clotrimazole Identified as a Selective UGT2B4 Inhibitor Using Canagliflozin-2'-<i>O</i>-Glucuronide Formation as a Selective UGT2B4 Probe Reaction.

Kimberly Lapham, Nicholas Ferguson, Mark Niosi

|Apr 02, 2024
Evaluation of Icotinib as a Potent and Selective Inhibitor of Aldehyde Oxidase for Reaction Phenotyping in Human Hepatocytes.

Lloyd Wei Tat Tang, Ethan DaSilva, Kimberly Lapham

|Oct 06, 2020
In Vitro Characterization of Ertugliflozin Metabolism by UDP-Glucuronosyltransferase and Cytochrome P450 Enzymes.

Kimberly Lapham, Ernesto Callegari, Julie Cianfrogna

Pageof 1